Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:gadoversetamide'
(id=6890400 ; fe=en:gadoversetamide ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1139 creation date=2017-06-25 touchdate=2024-11-21 05:27:32.000)
≈ 34 relations sortantes

  1. en:gadoversetamide -- r_associated #0: 29 / 1 -> en:methoxyethyl mercuriacetate
    n1=en:gadoversetamide | n2=en:methoxyethyl mercuriacetate | rel=r_associated | relid=0 | w=29
  2. en:gadoversetamide -- r_associated #0: 28 / 0.966 -> en:alkyl mercuric phosphate
    n1=en:gadoversetamide | n2=en:alkyl mercuric phosphate | rel=r_associated | relid=0 | w=28
  3. en:gadoversetamide -- r_associated #0: 27 / 0.931 -> en:organometallic compound
    n1=en:gadoversetamide | n2=en:organometallic compound | rel=r_associated | relid=0 | w=27
  4. en:gadoversetamide -- r_associated #0: 25 / 0.862 -> en:magnetic resonance contrast activity [moa]
    n1=en:gadoversetamide | n2=en:magnetic resonance contrast activity [moa] | rel=r_associated | relid=0 | w=25
  5. en:gadoversetamide -- r_associated #0: 25 / 0.862 -> en:polysiloxane/gadolinium chelates-based nanoparticles
    n1=en:gadoversetamide | n2=en:polysiloxane/gadolinium chelates-based nanoparticles | rel=r_associated | relid=0 | w=25
  6. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> citrate de magnésium
    n1=en:gadoversetamide | n2=citrate de magnésium | rel=r_associated | relid=0 | w=20
  7. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:bismuth subsalicylate
    n1=en:gadoversetamide | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=20
  8. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:carboxydextran-coated superparamagnetic iron oxide
    n1=en:gadoversetamide | n2=en:carboxydextran-coated superparamagnetic iron oxide | rel=r_associated | relid=0 | w=20
  9. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:copper 3-phenyl salicylate
    n1=en:gadoversetamide | n2=en:copper 3-phenyl salicylate | rel=r_associated | relid=0 | w=20
  10. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:ethylmercuric chloride
    n1=en:gadoversetamide | n2=en:ethylmercuric chloride | rel=r_associated | relid=0 | w=20
  11. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:fda established names and unique ingredient identifier codes terminology
    n1=en:gadoversetamide | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
  12. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadobenic acid
    n1=en:gadoversetamide | n2=en:gadobenic acid | rel=r_associated | relid=0 | w=20
  13. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadofosveset trisodium anhydrous
    n1=en:gadoversetamide | n2=en:gadofosveset trisodium anhydrous | rel=r_associated | relid=0 | w=20
  14. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadolinium-based contrast agent p03277
    n1=en:gadoversetamide | n2=en:gadolinium-based contrast agent p03277 | rel=r_associated | relid=0 | w=20
  15. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadopenamide
    n1=en:gadoversetamide | n2=en:gadopenamide | rel=r_associated | relid=0 | w=20
  16. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadoversetamide 0.5mmol/ml injection solution
    n1=en:gadoversetamide | n2=en:gadoversetamide 0.5mmol/ml injection solution | rel=r_associated | relid=0 | w=20
  17. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gadoxetic acid
    n1=en:gadoversetamide | n2=en:gadoxetic acid | rel=r_associated | relid=0 | w=20
  18. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:galsulfase
    n1=en:gadoversetamide | n2=en:galsulfase | rel=r_associated | relid=0 | w=20
  19. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:genadur
    n1=en:gadoversetamide | n2=en:genadur | rel=r_associated | relid=0 | w=20
  20. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:glucomannan
    n1=en:gadoversetamide | n2=en:glucomannan | rel=r_associated | relid=0 | w=20
  21. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:gonorrheal urethral secretion human
    n1=en:gadoversetamide | n2=en:gonorrheal urethral secretion human | rel=r_associated | relid=0 | w=20
  22. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:guaifenesin + theophylline
    n1=en:gadoversetamide | n2=en:guaifenesin + theophylline | rel=r_associated | relid=0 | w=20
  23. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:guaifenesin and oxtriphylline product
    n1=en:gadoversetamide | n2=en:guaifenesin and oxtriphylline product | rel=r_associated | relid=0 | w=20
  24. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:ionic gadolinium chelate
    n1=en:gadoversetamide | n2=en:ionic gadolinium chelate | rel=r_associated | relid=0 | w=20
  25. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:iron compounds, organic
    n1=en:gadoversetamide | n2=en:iron compounds, organic | rel=r_associated | relid=0 | w=20
  26. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:iron ferrite
    n1=en:gadoversetamide | n2=en:iron ferrite | rel=r_associated | relid=0 | w=20
  27. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:magnesium citrate
    n1=en:gadoversetamide | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=20
  28. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:metal-organic frameworks
    n1=en:gadoversetamide | n2=en:metal-organic frameworks | rel=r_associated | relid=0 | w=20
  29. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:nonionic gadolinium chelate
    n1=en:gadoversetamide | n2=en:nonionic gadolinium chelate | rel=r_associated | relid=0 | w=20
  30. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:nonionic macrocyclic gadolinium chelate
    n1=en:gadoversetamide | n2=en:nonionic macrocyclic gadolinium chelate | rel=r_associated | relid=0 | w=20
  31. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:organogold compounds
    n1=en:gadoversetamide | n2=en:organogold compounds | rel=r_associated | relid=0 | w=20
  32. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:Paris green
    n1=en:gadoversetamide | n2=en:Paris green | rel=r_associated | relid=0 | w=20
  33. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:paris green
    n1=en:gadoversetamide | n2=en:paris green | rel=r_associated | relid=0 | w=20
  34. en:gadoversetamide -- r_associated #0: 20 / 0.69 -> en:polyvinylpyrrolidone-sodium hyaluronate gel
    n1=en:gadoversetamide | n2=en:polyvinylpyrrolidone-sodium hyaluronate gel | rel=r_associated | relid=0 | w=20
≈ 37 relations entrantes

  1. en:paris green --- r_associated #0: 47 --> en:gadoversetamide
    n1=en:paris green | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=47
  2. en:Paris green --- r_associated #0: 45 --> en:gadoversetamide
    n1=en:Paris green | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=45
  3. en:bismuth subsalicylate --- r_associated #0: 37 --> en:gadoversetamide
    n1=en:bismuth subsalicylate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=37
  4. en:gadolinium-based contrast agent p03277 --- r_associated #0: 35 --> en:gadoversetamide
    n1=en:gadolinium-based contrast agent p03277 | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=35
  5. en:iron ferrite --- r_associated #0: 35 --> en:gadoversetamide
    n1=en:iron ferrite | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=35
  6. en:metal-organic frameworks --- r_associated #0: 35 --> en:gadoversetamide
    n1=en:metal-organic frameworks | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=35
  7. en:organogold compounds --- r_associated #0: 35 --> en:gadoversetamide
    n1=en:organogold compounds | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=35
  8. en:carboxydextran-coated superparamagnetic iron oxide --- r_associated #0: 34 --> en:gadoversetamide
    n1=en:carboxydextran-coated superparamagnetic iron oxide | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=34
  9. en:gadoxetic acid --- r_associated #0: 34 --> en:gadoversetamide
    n1=en:gadoxetic acid | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=34
  10. en:galsulfase --- r_associated #0: 34 --> en:gadoversetamide
    n1=en:galsulfase | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=34
  11. en:glucomannan --- r_associated #0: 34 --> en:gadoversetamide
    n1=en:glucomannan | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=34
  12. en:guaifenesin + theophylline --- r_associated #0: 34 --> en:gadoversetamide
    n1=en:guaifenesin + theophylline | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=34
  13. en:alkyl mercuric phosphate --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:alkyl mercuric phosphate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  14. en:gadopenamide --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:gadopenamide | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  15. en:genadur --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:genadur | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  16. en:ionic gadolinium chelate --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:ionic gadolinium chelate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  17. en:iron compounds, organic --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:iron compounds, organic | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  18. en:methoxyethyl mercuriacetate --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:methoxyethyl mercuriacetate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  19. en:nonionic gadolinium chelate --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:nonionic gadolinium chelate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  20. en:polysiloxane/gadolinium chelates-based nanoparticles --- r_associated #0: 32 --> en:gadoversetamide
    n1=en:polysiloxane/gadolinium chelates-based nanoparticles | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=32
  21. en:ethylmercuric chloride --- r_associated #0: 31 --> en:gadoversetamide
    n1=en:ethylmercuric chloride | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=31
  22. en:gonorrheal urethral secretion human --- r_associated #0: 31 --> en:gadoversetamide
    n1=en:gonorrheal urethral secretion human | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=31
  23. en:gadofosveset trisodium anhydrous --- r_associated #0: 30 --> en:gadoversetamide
    n1=en:gadofosveset trisodium anhydrous | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=30
  24. en:nonionic macrocyclic gadolinium chelate --- r_associated #0: 30 --> en:gadoversetamide
    n1=en:nonionic macrocyclic gadolinium chelate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=30
  25. en:magnetic resonance contrast activity [moa] --- r_associated #0: 29 --> en:gadoversetamide
    n1=en:magnetic resonance contrast activity [moa] | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=29
  26. en:polyvinylpyrrolidone-sodium hyaluronate gel --- r_associated #0: 29 --> en:gadoversetamide
    n1=en:polyvinylpyrrolidone-sodium hyaluronate gel | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=29
  27. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 28 --> en:gadoversetamide
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=28
  28. en:gadobenic acid --- r_associated #0: 28 --> en:gadoversetamide
    n1=en:gadobenic acid | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=28
  29. en:copper 3-phenyl salicylate --- r_associated #0: 27 --> en:gadoversetamide
    n1=en:copper 3-phenyl salicylate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=27
  30. en:guaifenesin and oxtriphylline product --- r_associated #0: 27 --> en:gadoversetamide
    n1=en:guaifenesin and oxtriphylline product | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=27
  31. en:magnesium citrate --- r_associated #0: 27 --> en:gadoversetamide
    n1=en:magnesium citrate | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=27
  32. citrate de magnésium --- r_associated #0: 26 --> en:gadoversetamide
    n1=citrate de magnésium | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=26
  33. en:gadoversetamide 0.5mmol/ml injection solution --- r_associated #0: 26 --> en:gadoversetamide
    n1=en:gadoversetamide 0.5mmol/ml injection solution | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=26
  34. en:phenyl mercuric salt --- r_associated #0: 25 --> en:gadoversetamide
    n1=en:phenyl mercuric salt | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=25
  35. en:organometallic compound --- r_associated #0: 20 --> en:gadoversetamide
    n1=en:organometallic compound | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=20
  36. Citrate de magnésium --- r_associated #0: 15 --> en:gadoversetamide
    n1=Citrate de magnésium | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=15
  37. E345 --- r_associated #0: 15 --> en:gadoversetamide
    n1=E345 | n2=en:gadoversetamide | rel=r_associated | relid=0 | w=15
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr